Literature DB >> 18939939

Molecular mechanisms underlying thalassemia intermedia in Iran.

Maryam Neishabury1, Azita Azarkeivan, Christian Oberkanins, Fatemehsadat Esteghamat, Naser Amirizadeh, Hossein Najmabadi.   

Abstract

To improve the differentiation of thalassemia intermedia from other hemoglobinopathies in Iran, four known genetic mechanisms-XmnI (G)gamma polymorphism, inheritance of mild and silent beta-thalassemia alleles, delta beta deletion, and coinheritance of alpha- and beta-thalassemia-were investigated in 52 Iranian individuals suspected to have thalassemia intermedia based on clinical and hematological characteristics. Beta-globin mutations were studied using a reverse-hybridization assay and sequencing of the total beta-globin gene. The XmnI (G)gamma polymorphism, the Sicilian delta beta deletion, and four alpha-globin mutations (-a(3.7), -a(4.2), -(MED), aaa(anti-3.7)) were studied using PCR-based techniques. The inheritance of the XmnI (G)gamma polymorphism with severe beta-thalassemia alleles in the homozygous or compound heterozygous state was the predominant mechanism observed in 27 individuals (55.3%). In five cases, this status overlapped with the -a(3.7)/aa genotype. The second most frequent cause for thalassemia intermedia (14.8%) was the inheritance of mild beta-thalassemia alleles, including IVS-I-6 (T > C), -88 (C > A), and + 113 (A > G). In three subjects (4.3%) the Sicilian delta beta deletion was identified. HbS in association with beta-zero-thalassemia was found in three patients with thalassemia intermedia phenotype. In 11 cases (21.3%) no causative genetic alteration could be identified. Our results reflect the diversity underlying thalassemia intermedia, and the limitations of the applied clinical, hematological, and molecular approaches for correct diagnosis. Some of the unresolved cases will offer an opportunity to discover additional molecular mechanisms leading to thalassemia intermedia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18939939     DOI: 10.1089/gte.2008.0018

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  6 in total

1.  The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity.

Authors:  Wanqun Chen; Xinhua Zhang; Xuan Shang; Ren Cai; Liyan Li; Tianhong Zhou; Manna Sun; Fu Xiong; Xiangmin Xu
Journal:  BMC Med Genet       Date:  2010-02-25       Impact factor: 2.103

2.  Role of XmnIgG Polymorphism in Hydroxyurea Treatment and Fetal Hemoglobin Level at Isfahanian Intermediate β-Thalassemia Patients.

Authors:  Majid Motovali-Bashi; Tayyebeh Ghasemi
Journal:  Iran Biomed J       Date:  2015-05-30

3.  β -thalassemia intermedia in Northern Iraq: a single center experience.

Authors:  Nasir A S Al-Allawi; Sana D Jalal; Ameen M Mohammad; Sharaza Q Omer; Raji S D Markous
Journal:  Biomed Res Int       Date:  2014-02-27       Impact factor: 3.411

4.  Xmn1-158 γGVariant in B-Thalassemia Intermediate Patients in South-East of Iran.

Authors:  Ebrahim Miri-Moghaddam; Sara Bahrami; Majid Naderi; Ali Bazi; Morteza Karimipoor
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01

5.  Molecular characterization of β-thalassemia intermedia in the West Bank, Palestine.

Authors:  Rashail Faraon; Mahmoud Daraghmah; Fekri Samarah; Mahmoud A Srour
Journal:  BMC Hematol       Date:  2019-02-18

6.  Genotype-phenotype association analysis identifies the role of α globin genes in modulating disease severity of β thalassaemia intermedia in Sri Lanka.

Authors:  Shiromi Perera; Angela Allen; Ishari Silva; Menaka Hapugoda; M Nirmali Wickramarathne; Indira Wijesiriwardena; Stephen Allen; David Rees; Dimitar G Efremov; Christopher A Fisher; David J Weatherall; Anuja Premawardhena
Journal:  Sci Rep       Date:  2019-07-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.